nodes	percent_of_prediction	percent_of_DWPC	metapath
Entecavir—Cladribine—hematologic cancer	0.533	1	CrCtD
Entecavir—Cladribine—Pentostatin—hematologic cancer	0.0475	0.129	CrCrCtD
Entecavir—Decitabine—Pentostatin—hematologic cancer	0.0452	0.123	CrCrCtD
Entecavir—Cladribine—Clofarabine—hematologic cancer	0.0423	0.115	CrCrCtD
Entecavir—Decitabine—Clofarabine—hematologic cancer	0.0403	0.11	CrCrCtD
Entecavir—Cladribine—Nelarabine—hematologic cancer	0.0398	0.108	CrCrCtD
Entecavir—Decitabine—Nelarabine—hematologic cancer	0.0379	0.103	CrCrCtD
Entecavir—Cladribine—Fludarabine—hematologic cancer	0.031	0.0846	CrCrCtD
Entecavir—Decitabine—Gemcitabine—hematologic cancer	0.0279	0.0761	CrCrCtD
Entecavir—Decitabine—Cytarabine—hematologic cancer	0.0279	0.0761	CrCrCtD
Entecavir—Decitabine—Cladribine—hematologic cancer	0.0272	0.0742	CrCrCtD
Entecavir—Decitabine—DNMT3A—hematologic cancer	0.000962	0.363	CrCbGaD
Entecavir—Decitabine—DCK—hematologic cancer	0.000755	0.285	CrCbGaD
Entecavir—Cladribine—DCK—hematologic cancer	0.000406	0.153	CrCbGaD
Entecavir—Aciclovir—SLC22A1—hematologic cancer	0.000301	0.114	CrCbGaD
Entecavir—Cladribine—SLC22A1—hematologic cancer	0.000131	0.0495	CrCbGaD
Entecavir—Cladribine—ABCG2—hematologic cancer	9.15e-05	0.0346	CrCbGaD
Entecavir—Somnolence—Etoposide—hematologic cancer	3.4e-05	0.00035	CcSEcCtD
Entecavir—Hepatobiliary disease—Methotrexate—hematologic cancer	3.39e-05	0.00035	CcSEcCtD
Entecavir—Nausea—Bortezomib—hematologic cancer	3.39e-05	0.00035	CcSEcCtD
Entecavir—Asthenia—Vincristine—hematologic cancer	3.38e-05	0.000349	CcSEcCtD
Entecavir—Vomiting—Thiotepa—hematologic cancer	3.38e-05	0.000349	CcSEcCtD
Entecavir—Diarrhoea—Carmustine—hematologic cancer	3.38e-05	0.000349	CcSEcCtD
Entecavir—Mental disorder—Prednisone—hematologic cancer	3.38e-05	0.000348	CcSEcCtD
Entecavir—Nausea—Bleomycin—hematologic cancer	3.36e-05	0.000347	CcSEcCtD
Entecavir—Malnutrition—Prednisone—hematologic cancer	3.36e-05	0.000346	CcSEcCtD
Entecavir—Rash—Thiotepa—hematologic cancer	3.35e-05	0.000346	CcSEcCtD
Entecavir—Dermatitis—Thiotepa—hematologic cancer	3.35e-05	0.000346	CcSEcCtD
Entecavir—Diarrhoea—Alitretinoin—hematologic cancer	3.35e-05	0.000345	CcSEcCtD
Entecavir—Headache—Thiotepa—hematologic cancer	3.33e-05	0.000344	CcSEcCtD
Entecavir—Diarrhoea—Ifosfamide—hematologic cancer	3.31e-05	0.000341	CcSEcCtD
Entecavir—Nausea—Vinorelbine—hematologic cancer	3.31e-05	0.000341	CcSEcCtD
Entecavir—Renal failure—Epirubicin—hematologic cancer	3.3e-05	0.000341	CcSEcCtD
Entecavir—Gastrointestinal disorder—Etoposide—hematologic cancer	3.3e-05	0.00034	CcSEcCtD
Entecavir—Body temperature increased—Cisplatin—hematologic cancer	3.3e-05	0.00034	CcSEcCtD
Entecavir—Asthenia—Irinotecan—hematologic cancer	3.3e-05	0.00034	CcSEcCtD
Entecavir—Asthenia—Mitoxantrone—hematologic cancer	3.3e-05	0.00034	CcSEcCtD
Entecavir—Fatigue—Etoposide—hematologic cancer	3.29e-05	0.00034	CcSEcCtD
Entecavir—Vomiting—Thalidomide—hematologic cancer	3.27e-05	0.000337	CcSEcCtD
Entecavir—Dizziness—Carmustine—hematologic cancer	3.27e-05	0.000337	CcSEcCtD
Entecavir—Neutropenia—Doxorubicin—hematologic cancer	3.26e-05	0.000336	CcSEcCtD
Entecavir—Rash—Thalidomide—hematologic cancer	3.24e-05	0.000335	CcSEcCtD
Entecavir—Dermatitis—Thalidomide—hematologic cancer	3.24e-05	0.000334	CcSEcCtD
Entecavir—Upper respiratory tract infection—Doxorubicin—hematologic cancer	3.24e-05	0.000334	CcSEcCtD
Entecavir—Dizziness—Alitretinoin—hematologic cancer	3.24e-05	0.000334	CcSEcCtD
Entecavir—Diarrhoea—Vincristine—hematologic cancer	3.23e-05	0.000333	CcSEcCtD
Entecavir—Headache—Thalidomide—hematologic cancer	3.22e-05	0.000332	CcSEcCtD
Entecavir—Hepatitis—Methotrexate—hematologic cancer	3.22e-05	0.000332	CcSEcCtD
Entecavir—Asthenia—Gemcitabine—hematologic cancer	3.21e-05	0.000331	CcSEcCtD
Entecavir—Haematuria—Epirubicin—hematologic cancer	3.2e-05	0.00033	CcSEcCtD
Entecavir—Dizziness—Ifosfamide—hematologic cancer	3.2e-05	0.00033	CcSEcCtD
Entecavir—Hepatobiliary disease—Epirubicin—hematologic cancer	3.18e-05	0.000328	CcSEcCtD
Entecavir—Nausea—Thiotepa—hematologic cancer	3.16e-05	0.000326	CcSEcCtD
Entecavir—Anaphylactic shock—Betamethasone—hematologic cancer	3.14e-05	0.000324	CcSEcCtD
Entecavir—Anaphylactic shock—Dexamethasone—hematologic cancer	3.14e-05	0.000324	CcSEcCtD
Entecavir—Hyperglycaemia—Doxorubicin—hematologic cancer	3.14e-05	0.000324	CcSEcCtD
Entecavir—Diarrhoea—Irinotecan—hematologic cancer	3.14e-05	0.000324	CcSEcCtD
Entecavir—Diarrhoea—Mitoxantrone—hematologic cancer	3.14e-05	0.000324	CcSEcCtD
Entecavir—Vomiting—Carmustine—hematologic cancer	3.14e-05	0.000324	CcSEcCtD
Entecavir—Insomnia—Triamcinolone—hematologic cancer	3.13e-05	0.000323	CcSEcCtD
Entecavir—Gastrointestinal pain—Etoposide—hematologic cancer	3.12e-05	0.000322	CcSEcCtD
Entecavir—Infection—Dexamethasone—hematologic cancer	3.12e-05	0.000322	CcSEcCtD
Entecavir—Infection—Betamethasone—hematologic cancer	3.12e-05	0.000322	CcSEcCtD
Entecavir—Dizziness—Vincristine—hematologic cancer	3.12e-05	0.000322	CcSEcCtD
Entecavir—Rash—Carmustine—hematologic cancer	3.12e-05	0.000321	CcSEcCtD
Entecavir—Dermatitis—Carmustine—hematologic cancer	3.11e-05	0.000321	CcSEcCtD
Entecavir—Vomiting—Alitretinoin—hematologic cancer	3.11e-05	0.000321	CcSEcCtD
Entecavir—Headache—Carmustine—hematologic cancer	3.1e-05	0.000319	CcSEcCtD
Entecavir—Rash—Alitretinoin—hematologic cancer	3.09e-05	0.000318	CcSEcCtD
Entecavir—Nervous system disorder—Dexamethasone—hematologic cancer	3.08e-05	0.000318	CcSEcCtD
Entecavir—Nervous system disorder—Betamethasone—hematologic cancer	3.08e-05	0.000318	CcSEcCtD
Entecavir—Dermatitis—Alitretinoin—hematologic cancer	3.08e-05	0.000318	CcSEcCtD
Entecavir—Vomiting—Ifosfamide—hematologic cancer	3.08e-05	0.000317	CcSEcCtD
Entecavir—Headache—Alitretinoin—hematologic cancer	3.07e-05	0.000316	CcSEcCtD
Entecavir—Diarrhoea—Gemcitabine—hematologic cancer	3.06e-05	0.000316	CcSEcCtD
Entecavir—Nausea—Thalidomide—hematologic cancer	3.06e-05	0.000315	CcSEcCtD
Entecavir—Renal failure—Doxorubicin—hematologic cancer	3.05e-05	0.000315	CcSEcCtD
Entecavir—Dyspepsia—Triamcinolone—hematologic cancer	3.05e-05	0.000315	CcSEcCtD
Entecavir—Rash—Ifosfamide—hematologic cancer	3.05e-05	0.000315	CcSEcCtD
Entecavir—Dermatitis—Ifosfamide—hematologic cancer	3.05e-05	0.000314	CcSEcCtD
Entecavir—Dizziness—Irinotecan—hematologic cancer	3.04e-05	0.000313	CcSEcCtD
Entecavir—Body temperature increased—Etoposide—hematologic cancer	3.02e-05	0.000312	CcSEcCtD
Entecavir—Abdominal pain—Etoposide—hematologic cancer	3.02e-05	0.000312	CcSEcCtD
Entecavir—Hepatitis—Epirubicin—hematologic cancer	3.02e-05	0.000311	CcSEcCtD
Entecavir—Vomiting—Vincristine—hematologic cancer	3e-05	0.000309	CcSEcCtD
Entecavir—Asthenia—Cisplatin—hematologic cancer	2.99e-05	0.000309	CcSEcCtD
Entecavir—Fatigue—Triamcinolone—hematologic cancer	2.99e-05	0.000308	CcSEcCtD
Entecavir—Rash—Vincristine—hematologic cancer	2.97e-05	0.000307	CcSEcCtD
Entecavir—Dermatitis—Vincristine—hematologic cancer	2.97e-05	0.000307	CcSEcCtD
Entecavir—Oedema peripheral—Epirubicin—hematologic cancer	2.97e-05	0.000306	CcSEcCtD
Entecavir—Haematuria—Doxorubicin—hematologic cancer	2.96e-05	0.000306	CcSEcCtD
Entecavir—Headache—Vincristine—hematologic cancer	2.96e-05	0.000305	CcSEcCtD
Entecavir—Hepatobiliary disease—Doxorubicin—hematologic cancer	2.94e-05	0.000303	CcSEcCtD
Entecavir—Nausea—Carmustine—hematologic cancer	2.94e-05	0.000303	CcSEcCtD
Entecavir—Vomiting—Irinotecan—hematologic cancer	2.92e-05	0.000301	CcSEcCtD
Entecavir—Vomiting—Mitoxantrone—hematologic cancer	2.92e-05	0.000301	CcSEcCtD
Entecavir—Immune system disorder—Methotrexate—hematologic cancer	2.91e-05	0.0003	CcSEcCtD
Entecavir—Nausea—Alitretinoin—hematologic cancer	2.91e-05	0.0003	CcSEcCtD
Entecavir—Rash—Mitoxantrone—hematologic cancer	2.9e-05	0.000299	CcSEcCtD
Entecavir—Rash—Irinotecan—hematologic cancer	2.9e-05	0.000299	CcSEcCtD
Entecavir—Dermatitis—Irinotecan—hematologic cancer	2.89e-05	0.000299	CcSEcCtD
Entecavir—Dermatitis—Mitoxantrone—hematologic cancer	2.89e-05	0.000299	CcSEcCtD
Entecavir—Headache—Irinotecan—hematologic cancer	2.88e-05	0.000297	CcSEcCtD
Entecavir—Headache—Mitoxantrone—hematologic cancer	2.88e-05	0.000297	CcSEcCtD
Entecavir—Nausea—Ifosfamide—hematologic cancer	2.87e-05	0.000296	CcSEcCtD
Entecavir—Diarrhoea—Cisplatin—hematologic cancer	2.85e-05	0.000294	CcSEcCtD
Entecavir—Alopecia—Methotrexate—hematologic cancer	2.85e-05	0.000294	CcSEcCtD
Entecavir—Vomiting—Gemcitabine—hematologic cancer	2.85e-05	0.000293	CcSEcCtD
Entecavir—Insomnia—Dexamethasone—hematologic cancer	2.84e-05	0.000293	CcSEcCtD
Entecavir—Insomnia—Betamethasone—hematologic cancer	2.84e-05	0.000293	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	2.84e-05	0.000293	CcSEcCtD
Entecavir—Mental disorder—Methotrexate—hematologic cancer	2.82e-05	0.000291	CcSEcCtD
Entecavir—Rash—Gemcitabine—hematologic cancer	2.82e-05	0.000291	CcSEcCtD
Entecavir—Dermatitis—Gemcitabine—hematologic cancer	2.82e-05	0.000291	CcSEcCtD
Entecavir—Malnutrition—Methotrexate—hematologic cancer	2.8e-05	0.000289	CcSEcCtD
Entecavir—Headache—Gemcitabine—hematologic cancer	2.8e-05	0.000289	CcSEcCtD
Entecavir—Nausea—Vincristine—hematologic cancer	2.8e-05	0.000289	CcSEcCtD
Entecavir—Hepatitis—Doxorubicin—hematologic cancer	2.79e-05	0.000288	CcSEcCtD
Entecavir—Dyspepsia—Betamethasone—hematologic cancer	2.77e-05	0.000286	CcSEcCtD
Entecavir—Dyspepsia—Dexamethasone—hematologic cancer	2.77e-05	0.000286	CcSEcCtD
Entecavir—Oedema peripheral—Doxorubicin—hematologic cancer	2.75e-05	0.000283	CcSEcCtD
Entecavir—Asthenia—Etoposide—hematologic cancer	2.74e-05	0.000283	CcSEcCtD
Entecavir—Body temperature increased—Triamcinolone—hematologic cancer	2.74e-05	0.000283	CcSEcCtD
Entecavir—Anaphylactic shock—Prednisone—hematologic cancer	2.74e-05	0.000283	CcSEcCtD
Entecavir—Nausea—Mitoxantrone—hematologic cancer	2.73e-05	0.000281	CcSEcCtD
Entecavir—Nausea—Irinotecan—hematologic cancer	2.73e-05	0.000281	CcSEcCtD
Entecavir—Immune system disorder—Epirubicin—hematologic cancer	2.72e-05	0.000281	CcSEcCtD
Entecavir—Infection—Prednisone—hematologic cancer	2.72e-05	0.000281	CcSEcCtD
Entecavir—Gastrointestinal disorder—Dexamethasone—hematologic cancer	2.72e-05	0.00028	CcSEcCtD
Entecavir—Gastrointestinal disorder—Betamethasone—hematologic cancer	2.72e-05	0.00028	CcSEcCtD
Entecavir—Fatigue—Betamethasone—hematologic cancer	2.71e-05	0.00028	CcSEcCtD
Entecavir—Fatigue—Dexamethasone—hematologic cancer	2.71e-05	0.00028	CcSEcCtD
Entecavir—Nervous system disorder—Prednisone—hematologic cancer	2.69e-05	0.000277	CcSEcCtD
Entecavir—Alopecia—Epirubicin—hematologic cancer	2.66e-05	0.000275	CcSEcCtD
Entecavir—Skin disorder—Prednisone—hematologic cancer	2.66e-05	0.000274	CcSEcCtD
Entecavir—Nausea—Gemcitabine—hematologic cancer	2.66e-05	0.000274	CcSEcCtD
Entecavir—Vomiting—Cisplatin—hematologic cancer	2.65e-05	0.000274	CcSEcCtD
Entecavir—Mental disorder—Epirubicin—hematologic cancer	2.64e-05	0.000272	CcSEcCtD
Entecavir—Rash—Cisplatin—hematologic cancer	2.63e-05	0.000271	CcSEcCtD
Entecavir—Dermatitis—Cisplatin—hematologic cancer	2.63e-05	0.000271	CcSEcCtD
Entecavir—Malnutrition—Epirubicin—hematologic cancer	2.62e-05	0.000271	CcSEcCtD
Entecavir—Diarrhoea—Etoposide—hematologic cancer	2.61e-05	0.00027	CcSEcCtD
Entecavir—Gastrointestinal pain—Dexamethasone—hematologic cancer	2.57e-05	0.000265	CcSEcCtD
Entecavir—Gastrointestinal pain—Betamethasone—hematologic cancer	2.57e-05	0.000265	CcSEcCtD
Entecavir—Dizziness—Etoposide—hematologic cancer	2.53e-05	0.000261	CcSEcCtD
Entecavir—Immune system disorder—Doxorubicin—hematologic cancer	2.52e-05	0.00026	CcSEcCtD
Entecavir—Leukopenia—Methotrexate—hematologic cancer	2.51e-05	0.000259	CcSEcCtD
Entecavir—Dizziness—Prednisolone—hematologic cancer	2.49e-05	0.000257	CcSEcCtD
Entecavir—Asthenia—Triamcinolone—hematologic cancer	2.49e-05	0.000257	CcSEcCtD
Entecavir—Body temperature increased—Betamethasone—hematologic cancer	2.49e-05	0.000256	CcSEcCtD
Entecavir—Abdominal pain—Betamethasone—hematologic cancer	2.49e-05	0.000256	CcSEcCtD
Entecavir—Abdominal pain—Dexamethasone—hematologic cancer	2.49e-05	0.000256	CcSEcCtD
Entecavir—Body temperature increased—Dexamethasone—hematologic cancer	2.49e-05	0.000256	CcSEcCtD
Entecavir—Nausea—Cisplatin—hematologic cancer	2.48e-05	0.000256	CcSEcCtD
Entecavir—Insomnia—Prednisone—hematologic cancer	2.48e-05	0.000256	CcSEcCtD
Entecavir—Alopecia—Doxorubicin—hematologic cancer	2.47e-05	0.000254	CcSEcCtD
Entecavir—Mental disorder—Doxorubicin—hematologic cancer	2.44e-05	0.000252	CcSEcCtD
Entecavir—Vomiting—Etoposide—hematologic cancer	2.43e-05	0.000251	CcSEcCtD
Entecavir—Malnutrition—Doxorubicin—hematologic cancer	2.43e-05	0.00025	CcSEcCtD
Entecavir—Dyspepsia—Prednisone—hematologic cancer	2.41e-05	0.000249	CcSEcCtD
Entecavir—Rash—Etoposide—hematologic cancer	2.41e-05	0.000249	CcSEcCtD
Entecavir—Dermatitis—Etoposide—hematologic cancer	2.41e-05	0.000248	CcSEcCtD
Entecavir—Headache—Etoposide—hematologic cancer	2.39e-05	0.000247	CcSEcCtD
Entecavir—Rash—Prednisolone—hematologic cancer	2.38e-05	0.000245	CcSEcCtD
Entecavir—Dermatitis—Prednisolone—hematologic cancer	2.37e-05	0.000245	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	2.37e-05	0.000245	CcSEcCtD
Entecavir—Fatigue—Prednisone—hematologic cancer	2.36e-05	0.000244	CcSEcCtD
Entecavir—Headache—Prednisolone—hematologic cancer	2.36e-05	0.000244	CcSEcCtD
Entecavir—Leukopenia—Epirubicin—hematologic cancer	2.35e-05	0.000242	CcSEcCtD
Entecavir—Dizziness—Triamcinolone—hematologic cancer	2.29e-05	0.000236	CcSEcCtD
Entecavir—Anaphylactic shock—Methotrexate—hematologic cancer	2.29e-05	0.000236	CcSEcCtD
Entecavir—Infection—Methotrexate—hematologic cancer	2.27e-05	0.000235	CcSEcCtD
Entecavir—Nausea—Etoposide—hematologic cancer	2.27e-05	0.000234	CcSEcCtD
Entecavir—Asthenia—Dexamethasone—hematologic cancer	2.26e-05	0.000233	CcSEcCtD
Entecavir—Asthenia—Betamethasone—hematologic cancer	2.26e-05	0.000233	CcSEcCtD
Entecavir—Nervous system disorder—Methotrexate—hematologic cancer	2.24e-05	0.000232	CcSEcCtD
Entecavir—Gastrointestinal pain—Prednisone—hematologic cancer	2.24e-05	0.000231	CcSEcCtD
Entecavir—Nausea—Prednisolone—hematologic cancer	2.24e-05	0.000231	CcSEcCtD
Entecavir—Skin disorder—Methotrexate—hematologic cancer	2.22e-05	0.000229	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	2.22e-05	0.000229	CcSEcCtD
Entecavir—Vomiting—Triamcinolone—hematologic cancer	2.2e-05	0.000227	CcSEcCtD
Entecavir—Rash—Triamcinolone—hematologic cancer	2.19e-05	0.000225	CcSEcCtD
Entecavir—Dermatitis—Triamcinolone—hematologic cancer	2.18e-05	0.000225	CcSEcCtD
Entecavir—Leukopenia—Doxorubicin—hematologic cancer	2.17e-05	0.000224	CcSEcCtD
Entecavir—Headache—Triamcinolone—hematologic cancer	2.17e-05	0.000224	CcSEcCtD
Entecavir—Body temperature increased—Prednisone—hematologic cancer	2.17e-05	0.000223	CcSEcCtD
Entecavir—Abdominal pain—Prednisone—hematologic cancer	2.17e-05	0.000223	CcSEcCtD
Entecavir—Diarrhoea—Betamethasone—hematologic cancer	2.15e-05	0.000222	CcSEcCtD
Entecavir—Diarrhoea—Dexamethasone—hematologic cancer	2.15e-05	0.000222	CcSEcCtD
Entecavir—Anaphylactic shock—Epirubicin—hematologic cancer	2.14e-05	0.000221	CcSEcCtD
Entecavir—Infection—Epirubicin—hematologic cancer	2.13e-05	0.00022	CcSEcCtD
Entecavir—Nervous system disorder—Epirubicin—hematologic cancer	2.1e-05	0.000217	CcSEcCtD
Entecavir—Skin disorder—Epirubicin—hematologic cancer	2.08e-05	0.000215	CcSEcCtD
Entecavir—Dizziness—Betamethasone—hematologic cancer	2.08e-05	0.000215	CcSEcCtD
Entecavir—Dizziness—Dexamethasone—hematologic cancer	2.08e-05	0.000215	CcSEcCtD
Entecavir—Insomnia—Methotrexate—hematologic cancer	2.07e-05	0.000214	CcSEcCtD
Entecavir—Nausea—Triamcinolone—hematologic cancer	2.06e-05	0.000212	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	2.05e-05	0.000212	CcSEcCtD
Entecavir—Somnolence—Methotrexate—hematologic cancer	2.03e-05	0.00021	CcSEcCtD
Entecavir—Dyspepsia—Methotrexate—hematologic cancer	2.01e-05	0.000208	CcSEcCtD
Entecavir—Vomiting—Betamethasone—hematologic cancer	2e-05	0.000206	CcSEcCtD
Entecavir—Vomiting—Dexamethasone—hematologic cancer	2e-05	0.000206	CcSEcCtD
Entecavir—Rash—Dexamethasone—hematologic cancer	1.98e-05	0.000205	CcSEcCtD
Entecavir—Rash—Betamethasone—hematologic cancer	1.98e-05	0.000205	CcSEcCtD
Entecavir—Anaphylactic shock—Doxorubicin—hematologic cancer	1.98e-05	0.000204	CcSEcCtD
Entecavir—Dermatitis—Dexamethasone—hematologic cancer	1.98e-05	0.000204	CcSEcCtD
Entecavir—Dermatitis—Betamethasone—hematologic cancer	1.98e-05	0.000204	CcSEcCtD
Entecavir—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.98e-05	0.000204	CcSEcCtD
Entecavir—Fatigue—Methotrexate—hematologic cancer	1.97e-05	0.000204	CcSEcCtD
Entecavir—Headache—Dexamethasone—hematologic cancer	1.97e-05	0.000203	CcSEcCtD
Entecavir—Headache—Betamethasone—hematologic cancer	1.97e-05	0.000203	CcSEcCtD
Entecavir—Infection—Doxorubicin—hematologic cancer	1.97e-05	0.000203	CcSEcCtD
Entecavir—Asthenia—Prednisone—hematologic cancer	1.97e-05	0.000203	CcSEcCtD
Entecavir—Nervous system disorder—Doxorubicin—hematologic cancer	1.94e-05	0.0002	CcSEcCtD
Entecavir—Insomnia—Epirubicin—hematologic cancer	1.94e-05	0.0002	CcSEcCtD
Entecavir—Skin disorder—Doxorubicin—hematologic cancer	1.93e-05	0.000199	CcSEcCtD
Entecavir—Somnolence—Epirubicin—hematologic cancer	1.9e-05	0.000196	CcSEcCtD
Entecavir—Dyspepsia—Epirubicin—hematologic cancer	1.89e-05	0.000194	CcSEcCtD
Entecavir—Diarrhoea—Prednisone—hematologic cancer	1.87e-05	0.000193	CcSEcCtD
Entecavir—Gastrointestinal pain—Methotrexate—hematologic cancer	1.87e-05	0.000193	CcSEcCtD
Entecavir—Nausea—Dexamethasone—hematologic cancer	1.87e-05	0.000193	CcSEcCtD
Entecavir—Nausea—Betamethasone—hematologic cancer	1.87e-05	0.000193	CcSEcCtD
Entecavir—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.85e-05	0.000191	CcSEcCtD
Entecavir—Fatigue—Epirubicin—hematologic cancer	1.85e-05	0.00019	CcSEcCtD
Entecavir—Dizziness—Prednisone—hematologic cancer	1.81e-05	0.000187	CcSEcCtD
Entecavir—Abdominal pain—Methotrexate—hematologic cancer	1.81e-05	0.000187	CcSEcCtD
Entecavir—Body temperature increased—Methotrexate—hematologic cancer	1.81e-05	0.000187	CcSEcCtD
Entecavir—Insomnia—Doxorubicin—hematologic cancer	1.79e-05	0.000185	CcSEcCtD
Entecavir—Somnolence—Doxorubicin—hematologic cancer	1.76e-05	0.000182	CcSEcCtD
Entecavir—Gastrointestinal pain—Epirubicin—hematologic cancer	1.75e-05	0.000181	CcSEcCtD
Entecavir—Dyspepsia—Doxorubicin—hematologic cancer	1.74e-05	0.00018	CcSEcCtD
Entecavir—Vomiting—Prednisone—hematologic cancer	1.74e-05	0.00018	CcSEcCtD
Entecavir—Rash—Prednisone—hematologic cancer	1.73e-05	0.000178	CcSEcCtD
Entecavir—Dermatitis—Prednisone—hematologic cancer	1.73e-05	0.000178	CcSEcCtD
Entecavir—Headache—Prednisone—hematologic cancer	1.72e-05	0.000177	CcSEcCtD
Entecavir—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.71e-05	0.000176	CcSEcCtD
Entecavir—Fatigue—Doxorubicin—hematologic cancer	1.71e-05	0.000176	CcSEcCtD
Entecavir—Abdominal pain—Epirubicin—hematologic cancer	1.69e-05	0.000175	CcSEcCtD
Entecavir—Body temperature increased—Epirubicin—hematologic cancer	1.69e-05	0.000175	CcSEcCtD
Entecavir—Asthenia—Methotrexate—hematologic cancer	1.64e-05	0.000169	CcSEcCtD
Entecavir—Nausea—Prednisone—hematologic cancer	1.63e-05	0.000168	CcSEcCtD
Entecavir—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.62e-05	0.000167	CcSEcCtD
Entecavir—Abdominal pain—Doxorubicin—hematologic cancer	1.57e-05	0.000162	CcSEcCtD
Entecavir—Body temperature increased—Doxorubicin—hematologic cancer	1.57e-05	0.000162	CcSEcCtD
Entecavir—Diarrhoea—Methotrexate—hematologic cancer	1.57e-05	0.000162	CcSEcCtD
Entecavir—Asthenia—Epirubicin—hematologic cancer	1.54e-05	0.000159	CcSEcCtD
Entecavir—Dizziness—Methotrexate—hematologic cancer	1.51e-05	0.000156	CcSEcCtD
Entecavir—Diarrhoea—Epirubicin—hematologic cancer	1.47e-05	0.000151	CcSEcCtD
Entecavir—Vomiting—Methotrexate—hematologic cancer	1.46e-05	0.00015	CcSEcCtD
Entecavir—Rash—Methotrexate—hematologic cancer	1.44e-05	0.000149	CcSEcCtD
Entecavir—Dermatitis—Methotrexate—hematologic cancer	1.44e-05	0.000149	CcSEcCtD
Entecavir—Headache—Methotrexate—hematologic cancer	1.43e-05	0.000148	CcSEcCtD
Entecavir—Asthenia—Doxorubicin—hematologic cancer	1.42e-05	0.000147	CcSEcCtD
Entecavir—Dizziness—Epirubicin—hematologic cancer	1.42e-05	0.000146	CcSEcCtD
Entecavir—Vomiting—Epirubicin—hematologic cancer	1.36e-05	0.00014	CcSEcCtD
Entecavir—Nausea—Methotrexate—hematologic cancer	1.36e-05	0.00014	CcSEcCtD
Entecavir—Diarrhoea—Doxorubicin—hematologic cancer	1.36e-05	0.00014	CcSEcCtD
Entecavir—Rash—Epirubicin—hematologic cancer	1.35e-05	0.000139	CcSEcCtD
Entecavir—Dermatitis—Epirubicin—hematologic cancer	1.35e-05	0.000139	CcSEcCtD
Entecavir—Headache—Epirubicin—hematologic cancer	1.34e-05	0.000138	CcSEcCtD
Entecavir—Dizziness—Doxorubicin—hematologic cancer	1.31e-05	0.000135	CcSEcCtD
Entecavir—Nausea—Epirubicin—hematologic cancer	1.27e-05	0.000131	CcSEcCtD
Entecavir—Vomiting—Doxorubicin—hematologic cancer	1.26e-05	0.00013	CcSEcCtD
Entecavir—Rash—Doxorubicin—hematologic cancer	1.25e-05	0.000129	CcSEcCtD
Entecavir—Dermatitis—Doxorubicin—hematologic cancer	1.25e-05	0.000129	CcSEcCtD
Entecavir—Headache—Doxorubicin—hematologic cancer	1.24e-05	0.000128	CcSEcCtD
Entecavir—Nausea—Doxorubicin—hematologic cancer	1.18e-05	0.000121	CcSEcCtD
